Munich Re price target lowered to EUR629 by Berenberg on revenue guidance cut

Munich Re reported a robust Q2 2025 net profit of EUR2.085 billion, recovering significantly from Q1, and maintained its full-year EUR6 billion profit target. However, the company reduced its FY25 reinsurance revenue guidance from EUR42 billion to EUR40 billion, prompting a 6.8% stock decline. Analyst sentiment is mixed: Berenberg lowered its price target but characterized the sell-off as "overdone" while maintaining a Hold rating, citing strong earnings power and diversification. Conversely, JPMorgan upgraded Munich Re to Overweight and raised its price target, expressing confidence in the company's capital return prospects despite a softening reinsurance market, highlighting divergent views on the stock's immediate valuation versus its long-term potential.

Analysis

Munich Re's Q2 2025 results present a conflicting picture for investors, characterized by strong current profitability against a weaker forward-looking revenue outlook. The company reported a net profit of €2.085 billion, a substantial recovery from the €1.1 billion in Q1, driven by a benign quarter with no large claims in its Property & Casualty Reinsurance division. Despite this performance, the company reduced its full-year 2025 reinsurance revenue guidance from €42 billion to €40 billion, which triggered a 6.8% decline in its stock price. Analyst reactions are divergent, reflecting this tension. Berenberg lowered its price target to €629.00 but maintained a Hold rating, labeling the market's negative reaction as "overdone" and highlighting the company's strong, diversified earnings power. In contrast, JPMorgan issued a more bullish signal, upgrading the stock to Overweight and raising its price target to €650.00, citing confidence in capital return prospects even amid a softening reinsurance market. This divergence suggests the market is currently weighing near-term revenue headwinds against the firm’s underlying profitability and long-term capital management strategy.

Key Decisions for Investors

• Investors should weigh the negative signal of the reduced FY25 revenue guidance against the company's maintained €6 billion net profit target and the strong Q2 profit recovery.
• The 6.8% share price correction may present an entry point for those aligned with JPMorgan's Overweight rating, which is predicated on strong capital return prospects despite market softness.
• Consider the conflicting analyst ratings as a key data point; Berenberg's 'Hold' suggests caution is warranted due to the cyclical downturn, while JPMorgan's 'Overweight' signals confidence in long-term fundamentals.
• Monitor future commentary on the reinsurance pricing cycle and the company's ability to deliver on capital returns, as these are the core drivers of the current bull versus bear debate.